Chuikyo Issues 2024 Reform Recommendation; 1,000 Yen Premium Set for Inpatient Biosimilar Use

February 14, 2024
Chuikyo Chairman Takashi Oshio (left) Hands over FY2024 Reimbursement Reform Recommendation to Senior Vice Health Minister Masakazu Hamachi on Feb. 14 The Central Social Insurance Medical Council, a key health ministry panel better known as Chuikyo, on February 14 issued...read more